Jill Leversage, Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 2,500 shares at $10.96 ($27K) on 2021-05-11, disclosed to the SEC on 2021-05-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AUPH | BUY | 2021-12-15 | $32K | — | Filing → |
| AUPH | BUY | 2021-02-02 | $26K | — | Filing → |